Resveratrol stimulates AMP kinase activity in neurons
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Resveratrol is a polyphenol produced by plants that has multiple beneficial activities similar to those associated with caloric restriction (CR), such as increased life span and delay in the onset of diseases associated with aging. CR improves neuronal health, and the global beneficial effects of CR have been postulated to be mediated by the nervous system. One key enzyme thought to be activated during CR is the AMP-activated kinase (AMPK), a sensor of cellular energy levels. AMPK is activated by increases in the cellular AMP:ATP ratio, whereupon it functions to help preserve cellular energy. In this regard, the regulation of dietary food intake by hypothalamic neurons is mediated by AMPK. The suppression of nonessential energy expenditure by activated AMPK along with the CR mimetic and neuroprotective properties of resveratrol led us to hypothesize that neuronal activation of AMPK could be an important component of resveratrol activity. Here, we show that resveratrol activated AMPK in Neuro2a cells and primary neurons in vitro as well as in the brain. Resveratrol and the AMPK-activating compound 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) promoted robust neurite outgrowth in Neuro2a cells, which was blocked by genetic and pharmacologic inhibition of AMPK. Resveratrol also stimulated mitochondrial biogenesis in an AMPK-dependent manner. Resveratrol-stimulated AMPK activity in neurons depended on LKB1 activity but did not require the NAD-dependent protein deacetylase SIRT1 during this time frame. These findings suggest that neuronal activation of AMPK by resveratrol could affect neuronal energy homeostasis and contribute to the neuroprotective effects of resveratrol.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Resveratrol treatment activates SIRT1, PGC-1α and AMPK [29, 145-148] and inhibits AKT [149] (Figure 4).”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [148]
Citations
Cites
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Mäkelä, T. P., Alessi, D. R., & Hardie, D. G. (2003) · Journal of Biology · doi:10.1186/1475-4924-2-28 · Cited by 1,665
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
Minokoshi, Y., Alquier, T., Furukawa, N., Kim, Y.-B., Lee, A., Xue, B., Mu, J., Foufelle, F., Ferré, P., Birnbaum, M. J., et al. (2004) · Nature · doi:10.1038/nature02440 · Cited by 1,637
Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589
Woods, A., Dickerson, K., Heath, R., Hong, S.-P., Momcilovic, M., Johnstone, S. R., Carlson, M., & Carling, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.005 · Cited by 1,392
Transcriptional regulatory circuits controlling mitochondrial biogenesis and function
Kelly, D. P., & Scarpulla, R. C. (2004) · Genes & Development · doi:10.1101/gad.1177604 · Cited by 1,243
Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS
Nisoli, E., Tonello, C., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Falcone, S., Valerio, A., Cantoni, O., Clementi, E., et al. (2005) · Science · doi:10.1126/science.1117728 · Cited by 1,107
Cited by
Items 201–300 of 733
mTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics
Zhang, H., Xiao, X., Pan, Z., & Dokudovskaya, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02493-4 · Cited by 123
Adenosine Monophosphate (AMP)-Activated Protein Kinase: A New Target for Nutraceutical Compounds
Marín-Aguilar, F., Pavillard, L., Giampieri, F., Bullón, P., & Cordero, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020288 · Cited by 98
Molecular Bases of Caloric Restriction Regulation of Neuronal Synaptic Plasticity
Fontán‐Lozano, Á., López‐Lluch, G., Delgado-Garcia, J. M., Navas, P., & Carrión, Á. M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8040-1 · Cited by 109
“Furthermore, resveratrol promotes neurite outgrowth and also stimulates mitochondrial biogenesis contributing to neuronal energy homeostasis and neuroprotection [142].”
BackgroundKovacic, P., & Somanathan, R. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.2.11147 · Cited by 116
Resveratrol: Challenges in Translation to the Clinic — A Critical Discussion
Subramanian, L., Youssef, S., Bhattacharya, S., Kenealey, J., Polans, A. S., & van Ginkel, P. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1486 · Cited by 103
“For example, resveratrol causes cell death in tumor cells but is effective as an antiapoptotic or protective agent in nerve cells (30).”
BackgroundOuzzine, M., Gulberti, S., Ramalanjaona, N., Magdalou, J., & Fournel‐Gigleux, S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00349 · Cited by 112
“These data strongly suggest that the neuroprotective effects of resveratrol could be mediated by the activation of AMPK in neurons (Dasgupta and Milbrandt, 2007).”
BackgroundWang, X., Lu, J., Xie, W., Lu, X., Liang, Y., Li, M., Wang, Z., Huang, X., Tang, M., Pfaff, D. W., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912625116 · Cited by 109
Tang, Q., Li, G., Wei, X., Zhang, J., Chiu, J., Hasenmayer, D., Zhang, D., & Zhang, H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.023 · Cited by 107
Greer, E. L., & Brunet, A. (2008) · Journal of Cell Science · doi:10.1242/jcs.021519 · Cited by 118
“AMPK is also activated by resveratrol (Baur et al., 2006; Dasgupta and Milbrandt, 2007; Zang et al., 2006).”
Gong, X., Wang, H., Ye, Y., Shu, Y.-G., Deng, Y., He, X., Lu, G., & Zhang, S. (2016) · PubMed Central · Cited by 115
Role of medicinal plants in neurodegenerative diseases
Ratheesh, G., Tian, L., Venugopal, J. R., Ezhilarasu, H., Sadiq, A., Fan, T.-P., & Ramakrishna, S. (2017) · Biomanufacturing Reviews · doi:10.1007/s40898-017-0004-7 · Cited by 96
“Dasgupta and Milbrandt [36] demonstrated the neuroprotective effect of Resveratrol, in which Resveratrol helps in stimulating AMP kinase and thereby affect neuronal homeostasis.”
BackgroundCichoń, N., Saluk, J., Gorniak, L., Przysło, Ł., & Bijak, M. (2020) · Antioxidants · doi:10.3390/antiox9111035 · Cited by 114
Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK
Yang, Y.-J., Hu, L., Xia, Y.-P., Jiang, C.-Y., Miao, C., Yang, C.-Q., Yuan, M., & Wang, L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0550-6 · Cited by 101
“The mechanism of resveratrol-induced neuroprotection is not clear, but many of its benefits are thought to activate adenosine monophosphate (AMP)-activated protein kinase (AMPK) [19].”
BackgroundLongevity Extension by Phytochemicals
Leonov, A., Arlia‐Ciommo, A., Piano, A., Svistkova, V., Lutchman, V., Medkour, Y., & Titorenko, V. I. (2015) · Molecules · doi:10.3390/molecules20046544 · Cited by 110
“These phytochemicals include resveratrol and caffeine; they both act as cytostatic agents that retard cellular and organismal growth because of their abilities to attenuate the pro-aging TOR signaling pathway, a key driver of proliferative growth in heterotrophic organisms [68,126,143–149].”
BackgroundPlant-derived neuroprotective agents in Parkinson's disease.
Fu, W., Zhuang, W., Zhou, S., & Wang, X. (2015) · Europe PMC (PubMed Central) · Cited by 127
Imler, T. J., & Petro, T. M. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.10.015 · Cited by 104
Resveratrol Attenuates Renal Hypertrophy in Early-Stage Diabetes by Activating AMPK
Ding, D.-F., You, N., Wu, X.-M., Xu, J.-R., Hu, A.-P., Ye, X.-L., Zhu, Q., Jiang, X.-Q., Miao, H., Liu, C., et al. (2010) · American Journal of Nephrology · doi:10.1159/000300388 · Cited by 100
“More recently, resveratrol was also shown to inhibit PDGF-induced mesangial cell proliferation and DNA synthesis by increasing cytosolic PTP1B activity [ ,”
BackgroundXing, S.-S., Yang, X.-Y., Zheng, T., Li, W.-J., Wu, D., Chi, J.-Y., Bian, F., Bai, X.-L., Wu, G.-J., Zhang, Y.-Z., et al. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.07.004 · Cited by 99
Dutta, D., Xu, J., Dirain, M. L. S., & Leeuwenburgh, C. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.011 · Cited by 103
“Both interventions can activate the 50 AMP-activated protein kinase (AMPK) pathway [44], which has been shown to enhance autophagic induction by phosphorylating ULK1 and activating the ULK1–Atg13–Atg17 complex (Fig.”
Pasinetti, G. M., Wang, J., Marambaud, P., Ferruzzi, M., Gregor, P., Knable, L. A., & Ho, L. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.014 · Cited by 97
“Resveratrol is a relatively potent activator of AMPK in cell cultures and in vivo in mice (Canto and Auwerx, 2010; Dasgupta and Milbrandt, 2007; Hawley et al., 2010; Vingtdeux et al., 2010).”
BackgroundEffect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation
Natella, F., Nardini, M., Belelli, F., Pignatelli, P., Di Santo, S., Ghiselli, A., Violi, F., & Scaccini, C. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508981459 · Cited by 96
“In fact, many of the effects claimed for these compounds are exerted inside the cells (34,35) , but, unfortunately, no direct evidence exists about the ‘physiological’ presence of these compounds in cells in in vivo studies.”
Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy
Calcutt, N. A., Smith, D. R., Frizzi, K. E., Sabbir, M. G., Chowdhury, S. R., Mixcoatl-Zecuatl, T., Saleh, A. J., Muttalib, N., der Ploeg, R. V., Ochoa, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88321 · Cited by 105
“For example, the AMPK activator resveratrol enhances neurite outgrowth (14), while augmented AMPK signaling maintains outer retina synapses (15) and directs mitochondria to axons to drive branching in cerebellar granule neurons (16).”
BackgroundAMPK: An emerging target for modification of injury-induced pain plasticity
Price, T. J., & Dussor, G. O. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.060 · Cited by 103
“While there is still ample controversy over the relative contribution of SIRT1 or AMPK for the actions of resveratrol, it is now clear that AMPK plays an important role in resveratrol’s effects [22, 27, 36, 103].”
BackgroundJing, Y.-H., Chen, K.-H., Kuo, P.-C., Pao, C.-C., & Chen, J.-K. (2013) · Neuroendocrinology · doi:10.1159/000350435 · Cited by 93
Up-regulation of Adiponectin by Resveratrol
Wang, A., Liu, M., Liu, X., Dong, L. Q., Glickman, R. D., Slaga, T. J., Zhou, Z., & Liu, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188144 · Cited by 92
Wei, J., Ghosh, A. K., Chu, H., Fang, F., Hinchcliff, M., Wang, J., Marangoni, R. G., & Varga, J. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39061 · Cited by 98
“While resveratrol has been shown to be an activator of SIRT1 (24), it can also activate AMP kinase and other enzymes in a cell type–specific manner (25).”
BackgroundResveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex
Schweiger, S., Matthes, F., Posey, K., Kickstein, E., Weber, S., Hettich, M. M., Pfurtscheller, S., Ehninger, D., Schneider, R., & Krauß, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12974-4 · Cited by 89
Functional modulation of AMP-activated protein kinase by cereblon
Lee, K. M., Jo, S., Kim, H., Lee, J., & Park, C.-S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.005 · Cited by 93
Arsenic Inhibits Neurite Outgrowth by Inhibiting the LKB1–AMPK Signaling Pathway
Wang, X., Meng, D., Chang, Q., Pan, J., Zhang, Z., Chen, G., Ke, Z., Luo, J., & Shi, X. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901510 · Cited by 89
“In response to serum starvation or treatment with retinoic acid (RA) or dibutyryl cyclic AMP, N2a cells undergo neuronal differentiation characterized by cell cycle arrest, neurite outgrowth, and up-regulation of neuro filament (NF) proteins (Dasgupta and Milbrandt 2007).”
BackgroundInfluentialFrontier of Epilepsy Research - mTOR signaling pathway
Cho, C.-H. (2011) · Experimental and Molecular Medicine · doi:10.3858/emm.2011.43.5.032 · Cited by 93
“Resveratrol inhibits mTORC1 activity by promoting mTOR/DEPTOR and by activating LKB1/AMPK or SIRT1-TSC1/2 and inhibiting PI3K (Dasgupta and Milbrandt, 2007; Frojdo et al., 2007; Ghosh et al., 2010; Liu et al., 2010).”
BackgroundRoles of SIRT1 in the acute and restorative phases following induction of inflammation
Zhang, Z., Lowry, S. F., Guarente, L., & Haimovich, B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.174482 · Cited by 92
Zhu, Z., Li, R., Fan, X., Lv, Y., Zheng, Y., Hoque, S. A. M., Wu, D., & Zeng, W. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5921503 · Cited by 99
“Moreover, the activation of AMPK by resveratrol in somatic cells was revealed through a variety of mechanisms in previous studies [56, 57].”
Wang, R., Liu, Y., Liu, X., Jia, S., Zhao, J., Cui, D., & Wang, L. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366304 · Cited by 91
Metabolic Aspects of Adenosine Functions in the Brain
Garcia‐Gil, M., Camici, M., Allegrini, S., Pesi, R., & Tozzi, M. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.672182 · Cited by 96
Shaito, A. A., Al‐Mansoob, M., Ahmad, S. M. S., Haider, M. Z., Eid, A. H., Posadino, A. M., Pintus, G., & Giordo, R. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666221012122855 · Cited by 96
Cheng, P., Ho, W., Su, Y., Lu, P., Chen, B., Cheng, W., Lu, W., Sun, G., Yeh, T., Hsiao, M., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12648 · Cited by 96
“Resveratrol has neuroprotective properties and is a potent activator of AMPK in neuronal cell lines, primary neurons and the brain (Dasgupta and Milbrandt, 2007).”
BackgroundCsiszár, A., Csiszar, A., Pinto, J. T., Gautam, T., Kleusch, C., Hoffmann, B., Tucsek, Z., Toth, P., Sonntag, W. E., & Ungvari, Z. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu029 · Cited by 85
Take a break--resveratrol in action on DNA
Gatz, S. A., & Wiesmüller, L. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm276 · Cited by 103
Bottani, E., Lamperti, C., Prigione, A., Tiranti, V., Persico, N., & Brunetti, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111083 · Cited by 97
“Some authors reported that RSV acts primarily on AMPK activation [115,116], and that the activation of SIRT1 by RSV is an artifact [117–119].”
BackgroundMetabolic Vulnerability in the Neurodegenerative Disease Glaucoma
Inman, D. M., & Harun-Or-Rashid, M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00146 · Cited by 88
“Resveratrol also induced phosphorylation of AMPK, a master regulator of energy homeostasis (Dasgupta and Milbrandt, 2007), which when activated, stimulates glucose uptake in the brain (Hardie et al.”
BackgroundResveratrol-Induced Sirt1 Activation Derives from Sirt1 Phosphorylation by LKB1
Huang, Y., Lu, J., Li, Z., Wang, M., Shi, R., Yuan, X. N., Gao, X., Liu, X., Zang, J., Liu, W., et al. (2020) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100929 · Cited by 89
“Inversely, AMPK activity was significantly reduced in resveratrol-treated LKB1-depleted cells, whereas Sirt1 knockdown had no effect (data not shown), consistent with previous findings that resveratrolstimulated AMPK activity in neurons depended on LKB1 activity but did not require the NAD-dependent protein deacetylas…”
BackgroundInfluentialKuno, A., Hori, Y. S., Hosoda, R., Tanno, M., Miura, T., Shimamoto, K., & Horio, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.392050 · Cited by 88
“Although AMP-dependent protein kinase is reported to be a target of resveratrol (18), phosphorylation of AMP-dependent protein kinase and its downstream target acetyl-CoA carboxylase was not modulated by resveratrol (supplemental Fig.”
BackgroundPharmacological Strategies to Retard Cardiovascular Aging
Alfaras, I., Di Germanio, C., Bernier, M., Csiszar, A., Ungvari, Z., Lakatta, E. G., & de Cabo, R. (2016) · Circulation Research · doi:10.1161/circresaha.116.307475 · Cited by 87
Current nutritional and pharmacological anti-aging interventions
Ros, M., & Carrascosa, J. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165612 · Cited by 86
Anekonda, T. S., Wadsworth, T. L., Sabin, R., Frahler, K., Harris, C., Petriko, B., Ralle, M., Woltjer, R., & Quinn, J. F. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2010-101287 · Cited by 86
Sadı, G., Bozan, D., & Yildiz, H. B. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2051-1 · Cited by 99
The zebrafish embryo as a dynamic model of anoxia tolerance
Mendelsohn, B. A., Kassebaum, B., & Gitlin, J. D. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21581 · Cited by 92
“The AMP/ATP ratio was determined by HPLC analysis using five embryos per sample, three samples per condition, as described previously (Dasgupta and Milbrandt, 2007).”
MethodP53 coordinates decidual sestrin 2/AMPK/mTORC1 signaling to govern parturition timing
Deng, W., Cha, J., Yuan, J., Haraguchi, H., Bartos, A., Leishman, E., Viollet, B., Bradshaw, H. B., Hirota, Y., & Dey, S. K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87715 · Cited by 85
Ribarič, S. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/741468 · Cited by 107
“AMPK stimulation by RSV [251].”
Hormesis does not make sense except in the light of TOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100411 · Cited by 78
“Resveratrol indirectly antagonizes the mTOR/S6K pathway upstream and downstream [129, 149-153], in part via activation of AMPK and sirtuins [154-160].”
BackgroundWeisová, P., Dávila, D., Tuffy, L. P., Ward, M. W., Concannon, C. G., & Prehn, J. H. M. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3544 · Cited by 89
“…factor-kappa B, and may have effects on transcription complex formation by adapting rRNA synthesis to changes in cellular energy availability (29, 32, 52, 71, 118) ( The adenylate kinase reaction (2 ADP $ ATP þ AMP) is in close equilibrium, making the resultant AMP:ATP ratio a more sensitive…”
Chowdhury, S. K. R., Dobrowsky, R. T., & Fernyhough, P. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.06.007 · Cited by 82
“Resveratrol activates AMPK in cultured neurons (Dasgupta and Milbrandt, 2007) and in animal models of Huntington and Alzheimer's disease, PGC-1α and SIRT1 are protective (Kim et al., 2007; St-Pierre et al., 2006).”
The controversial links among calorie restriction, SIRT1, and resveratrol
Hu, Y., Liu, J., Wang, J., & Liu, Q. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.034 · Cited by 93
“compounds on resveratrol activity [54,56,61,62,65,67,78,87,90,91], Dasgupta and Milbrandt [93] reported that none of these three SIRT1 inhibitors (nicotinamide, sirtinol, and splitomicin) prevented resveratrol-inducedphosphorylation of AMP-activatedkinase (AMPK) inmouse”
BackgroundResultYadav, E., Yadav, P. S., Khan, M. M. U., Singh, H., & Verma, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.922232 · Cited by 93
“The responsible mechanism for the beneficial effect of RES is possibly through modulation of AMPK signaling pathway because inhibition of AMPK causes a significant reduction in mitochondrial markers (Dasgupta and Milbrandt, 2007).”
BackgroundThe mechanism of neuroprotective action of natural compounds
Wąsik, A., & Antkiewicz‐Michaluk, L. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.03.018 · Cited by 88
Sherman, S. P., & Bang, A. G. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031906 · Cited by 84
“…to inhibit neurites (Kasaba et al., 2003), and the polyphenol resveratrol, previously reported to promote neurite outgrowth in N2a and PC12 cells (Dasgupta and Milbrandt, 2007; Sugino et al., 2010), but identified in our screen as inhibitory to neurites, differences that could be explained by…”
Resveratrol and cognitive decline: a clinician perspective
Cicero, A. F. G., Ruscica, M., & Banach, M. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.85463 · Cited by 86
“These effects are independent of SIRT1 involvement, evidence supported by the use of SIRT1 inhibitors or studies conducted in the brain of SIRT1 knock-out mice [15].”
BackgroundSantiago, A. P. S. A., Chaves, E. A., de Oliveira, M. F., & Galina, A. (2008) · Biochimie · doi:10.1016/j.biochi.2008.06.013 · Cited by 89
Krishan, S., Richardson, D. R., & Sahni, S. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095810 · Cited by 90
“in many different cell lines (Dasgupta and Milbrandt, 2007; Park et al., 2007; Um et al., 2010).”
Exercise in a Pill: The Latest on Exercise-Mimetics
Guerrieri, D., Moon, H. Y., & van Praag, H. (2016) · Brain Plasticity · doi:10.3233/bpl-160043 · Cited by 85
“Resveratrol has additionally been shown to promote developmental neurogenesis via SIRT1- and AMPK-dependent mechanisms in vitro [115].”
BackgroundMoriya, J., Chen, R., Yamakawa, J.-I., Sasaki, K., Ishigaki, Y., & Takahashi, T. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.354 · Cited by 78
Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling
Han, Y., Jiang, C., Tang, J., Wang, C., Wu, P., Zhang, G., Liu, W., Jamangulova, N., Wu, X., & Song, X. (2014) · European Journal of Pain · doi:10.1002/ejp.511 · Cited by 82
“Previous studies have shown that resveratrol is a highly potent and efficacious activator of AMPK (Zang et al., 2006; Dasgupta and Milbrandt, 2007) and its metabolic effects are dependent upon α-subunit AMPK expression (Um et al., 2010).”
BackgroundShi, H., Xu, C., Liu, M., Wang, B., Liu, W., Chen, D.-H., Zhang, L., Xu, C., & Li, X. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01258 · Cited by 84
“According to a previous literature, resveratrol could inhibit the activity of ATP synthase in rats, as might consequently lead to a decrease of ATP content and the ATP/AMP ratio, but the increase of AMP level (Zheng and Ramirez, 2000; Dasgupta and Milbrandt, 2007).”
BackgroundLee, K. M., Yang, S.-J., Kim, Y. D., Choi, Y. D., Nam, J. H., Choi, C. S., Choi, H.-S., & Park, C.-S. (2013) · Diabetes · doi:10.2337/db12-1030 · Cited by 77
“Subsequently, the effects of Crbn KO were investigated under conditions known to activate endogenous AMPK (13,14).”
BackgroundSIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol
Fullerton, M. D., & Steinberg, G. R. (2010) · Diabetes · doi:10.2337/db09-1732 · Cited by 77
“The acute activation of AMPK by resveratrol appears to be independent of SIRT1 (10) and is potentially mediated by AMP because resveratrol inhibits the mitochondrial F1 ATPase (11).”
BackgroundThe Importance of NAD in Multiple Sclerosis
Penberthy, W., & Tsunoda, I. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787185751 · Cited by 75
“Resveratrol strongly promotes neurite outgrowth in Neuro2a cells in a SIRT1 independent but AMPK-dependent fashion [245].”
BackgroundNamsi, A., Nury, T., Hamdouni, H., Yammine, A., Vejux, A., Vervandier-Fasseur, D., Latruffe, N., Masmoudi-Kouki, O., & Lizard, G. (2018) · Diseases · doi:10.3390/diseases6030067 · Cited by 72
“N2a cells are broadly used to study the neuronal differentiation mechanism and neurite outgrowth [45].”
BackgroundYang, A. J. T., Bagit, A., & MacPherson, R. E. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094628 · Cited by 83
Lee, J.-H., Moon, J.-H., Kim, S.-W., Jeong, J.-K., Nazim, U. M., Lee, Y.-J., Seol, J.-W., & Park, S.-Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3832 · Cited by 76
“All of these key target proteins activated by sirt1 are essential for attenuating mitochondrial damage and oxidative stress [32, 35-37].”
BackgroundYu, L., & Yang, S. J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.063 · Cited by 83
“Recent studies demontrated that activation of AMPK by resveratrol or AICAR romotes neurite outgrowth and mitochondrial biogenesis, ffects neuronal energy homeostasis and contributes to he neuroprotective properties of resveratrol in neurons Dasgupta and Milbrandt, 2007).”
BackgroundPeng, Y., Liu, J., Shi, L., Tang, Y., Gao, D., Long, J., & Liu, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13563 · Cited by 75
“2012), and neuronal viability (Dasgupta and Milbrandt 2007), whereas AMPK inactivation leads to both insulin resistance (Liu et al.”
BackgroundAghanoori, M., Smith, D. R., Shariati‐Ievari, S., Ajisebutu, A. A., Nguyen, A. D., Desmond, F., Jesus, C. H. A., Zhou, X., Calcutt, N. A., Aliani, M., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.11.008 · Cited by 80
“Resveratrol, an activator of AMPK, drives axonal outgrowth and was protective against diabetic neuropathy in STZ-induced diabetic rats [44,54].”
BackgroundBastin, J., Lopes-Costa, A., & Djouadi, F. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr089 · Cited by 72
Saito, M., Saito, M., & Das, B. C. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.01.007 · Cited by 74
“AMPK has been observed not only in the peripheral tissues but also in hypothalamic neurons, cortical neurons, and Neuro2a cells (Dasgupta and Milbrandt, 2007; Landree et al., 2004).”
BackgroundChen, G., Bower, K. A., Xu, M., Ding, M., Shi, X., Ke, Z., & Luo, J. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9036-y · Cited by 75
“In response to serum starvation or treatment with retinoic acid (RA) or dibutyryl cAMP, N2a cells undergo neuronal differentiation characterized by cell cycle arrest, neurite outgrowth and up-regulation of neurofilament (NF) proteins (De Girolamo et al. 2000; Dasgupta and Milbrandt 2007).”
Resveratrol: New Avenues for a Natural Compound in Neuroprotection
Pallàs, M., Porquet, D., Vicente, A., & Sanfeliu, C. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319380005 · Cited by 83
“For example, several studies showed that resveratrol is a potent activator of AMPK in neuronal cell lines, primary neurons, and the brain [49] but these resveratrol-mediated AMPK activation during were independent of SIRT1.”
BackgroundResveratrol in the treatment of pancreatic cancer
Xu, Q., Zong, L., Chen, X., Jiang, Z., Nan, L., Li, J., Duan, W., Lei, J., Zhang, L., Ma, J., et al. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12837 · Cited by 78
SIRT1 Modulation as a Novel Approach to the Treatment of Diseases of Aging
Blum, C. A., Ellis, J. L., Loh, C., Ng, P. Y., Perni, R. B., & Stein, R. L. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100861p · Cited by 73
Amato, S., & Man, H. (2011) · Cell Cycle · doi:10.4161/cc.10.20.17953 · Cited by 82
Mouchiroud, L., Molin, L., Dallière, N., & Solari, F. (2010) · BioFactors · doi:10.1002/biof.127 · Cited by 73
“Furthermore, AMPK activation by RSV in neurons is LKB1 dependent but SIRT1 independent [41].”
BackgroundArzola‐Paniagua, M. A., García‐Salgado López, E. R., Calvo‐Vargas, C. G., & Guevara‐Cruz, M. (2016) · Obesity · doi:10.1002/oby.21523 · Cited by 64
“Resveratrol also acts against obesity-related diseases by improving mitochondrial function, improving insulin sensitivity and decreasing lipid accumulation (1,6,7).”
BackgroundPromise of resveratrol for easing status epilepticus and epilepsy
Shetty, A. K. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.008 · Cited by 80
“Furthermore, RESV stimulates AMP kinase activity in Neuro2a cells and primary neurons in vitro, and neurons in the adult brain (Dasgupta & Milbrandt, 2007).”
BackgroundTang, F., Guo, S., Liao, H., Yu, P., Wang, L., Song, X., Chen, J., & Yang, Q. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000481611 · Cited by 72
Leyton, L., Hott, M., Acuña, F., Caroca, J., Nuñez, M., Martín, C., Zambrano, Á., Concha, M. I., & Otth, C. (2015) · Virus Research · doi:10.1016/j.virusres.2015.05.015 · Cited by 76
Kumar, V., Pandey, A., Jahan, S., Shukla, R. K., Kumar, D., Srivastava, A., Singh, S., Rajpurohit, C. S., Yadav, S., Khanna, V. K., et al. (2016) · Scientific Reports · doi:10.1038/srep28142 · Cited by 74
Puissant, A., Grosso, S., Jacquel, A., Belhacène, N., Colosetti, P., Cassuto, J., & Auberger, P. (2008) · The FASEB Journal · doi:10.1096/fj.07-101394 · Cited by 73
Srivastava, S., & C. Haigis, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072526 · Cited by 70
Madhyastha, S., Sekhar, S., & Rao, G. M. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.06.010 · Cited by 72
“In another report (Dasgupta and Milbrandt, 2007), resveratrol induced neurogenesis by enhancing AMP-activated protein kinase (AMPK) in neurons and in Sirt1-deficient mice brain.”
BackgroundSynapto-Protective Drugs Evaluation in Reconstructed Neuronal Network
Deleglise, B., Lassus, B., Soubeyre, V., Alleaume‐Butaux, A., Hjorth, J. J. J., Vignes, M., Schneider, B., Brugg, B., Viovy, J., & Peyrin, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071103 · Cited by 75
“Resveratrol that activates several sirtuins through indirect signaling pathways involving both AMPK activation and NAD+ production [37,38], has been shown to have a similar axo-protective effect, once applied to entire neurons [34].”
BackgroundNutraceuticals in Parkinson’s Disease
Hang, L., Basil, A. H., & Lim, K. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8398-6 · Cited by 71
“…to different forms of PD. Consistent with our results, Ferretta et al. demonstrated similar benefits using resveratrol (Fer- retta et al. 2014), another nutraceutical found in the skin of grapes and berries that is known to be a relatively strong AMPK activator (Dasgupta and Milbrandt 2007).”
ResultVallianou, N. G., Evangelopoulos, A. A., & Kazazis, C. E. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.236 · Cited by 78
“Recently, it has been reported that SIRT1 is essential for moderate doses of RSV to stimulate AMPK and improve mitochondrial function in vitro and in vivo [37].”
BackgroundPlant polyphenols as natural drugs for the management of Down syndrome and related disorders
Vacca, R. A., Valenti, D., Caccamese, S., Daglia, M., Braidy, N., & Nabavi, S. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.023 · Cited by 75
Khusbu, F. Y., Zhou, X., Roy, M., Chen, F.-Z., Cao, Q., & Chen, H. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105644 · Cited by 71
Park, S. Y., Lee, H. R., Lee, W. S., Shin, H. K., Kim, H. Y., Hong, K. W., & Kim, C. D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160620 · Cited by 67
“Consistent with a report [33], resveratrol (20 μM) significantly increased the expression of P-AMPKα and of its downstream target P-ACC in N2a cells.”
BackgroundBrain response to calorie restriction
Fusco, S., & Pani, G. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1223-y · Cited by 73
“AMPK phosphorylates and inhibits Acetyl-CoA carboxylase (ACC), thus reducing the biosynthesis of malonyl-CoA [35], in the context of a general metabolic cell reprogramming whereby catabolic reactions are favored at expenses of anabolic processes, to cope with nutrient shortage.”
BackgroundInfluentialProtective effects of AMP‐activated protein kinase in the cardiovascular system
Xu, Q., & Si, L. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01179.x · Cited by 73
“found that resveratrol protects neurons through stimulation of AMPK activity [118].”
BackgroundMediobasal Hypothalamic SIRT1 Is Essential for Resveratrol’s Effects on Insulin Action in Rats
Knight, C. M., Gutierrez-Juarez, R., Lam, T. K. T., Arrieta-Cruz, I., Huang, L., Schwartz, G., Barzilai, N., & Rossetti, L. (2011) · Diabetes · doi:10.2337/db10-0987 · Cited by 66
“Resveratrol has been reported to activate AMPK in neuronal cell lines and in brain tissue in vivo (41).”
BackgroundMetabolic engineering and in vitro biosynthesis of phytochemicals and non-natural analogues
Mora‐Pale, M., Sánchez-Rodríguez, S. P., Linhardt, R. J., Dordick, J. S., & Koffas, M. A. G. (2013) · Plant Science · doi:10.1016/j.plantsci.2013.05.005 · Cited by 73
“Over more than a decade, resveratrol has also been shown to have cancer chemopreventive activity, to reduce the risk of coronary heart disease, and shows biological activity against Alzheimer’s disease [49–52].”
BackgroundKober, K. M., Olshen, A. B., Conley, Y. P., Schumacher, M. A., Topp, K. S., Smoot, B. J., Mazor, M. B., Chesney, M. A., Hammer, M. J., Paul, S. M., et al. (2018) · Molecular Pain · doi:10.1177/1744806918816462 · Cited by 69
Geroscience and pathology: a new frontier in understanding age-related diseases
Fekete, M., Major, D., Fehér, Á., Fazekas‐Pongor, V., & Lehoczki, A. (2024) · Pathology & Oncology Research · doi:10.3389/pore.2024.1611623 · Cited by 70
Metadata
- Authors
- Dasgupta, B., & Milbrandt, J.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-04-24
- Volume
- 104
- Issue
- 17
- Pages
- 7217-7222
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1855377
- OpenAlex
- W2096361448
- Cited by
- 723
- References
- 49
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 18 · 2023: 19 · 2022: 22 · 2021: 27 · 2020: 28 · 2019: 31 · 2018: 43 · 2017: 39 · 2016: 44 · 2015: 42 · 2014: 45 · 2013: 62 · 2012: 53
- FWCI
- 24.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hope Center for Neurological Disorders
- National Institutes of Health (AG13730, NS057105)
- National Institute on Aging (AG 13730, RF1AG013730, R56AG013730, R01AG013730)
- National Institute of Neurological Disorders and Stroke (NS39358, P30NS057105, NS057105, R01NS039358)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- resveratrol, AMPK, neurons, caloric restriction mimetics, neurite outgrowth, mitochondrial biogenesis, LKB1, SIRT1, neuroprotection, AICAR, N2a cells
- MeSH terms
- Resveratrol, Adenylate Kinase, Aminoimidazole Carboxamide, Animals, Brain, Enzyme Activation, Ganglia, Spinal, Male, Mitochondria, Neurons, Neurons, Afferent, Phosphorylation, Ribonucleotides, Stilbenes, Neurites, Protein Serine-Threonine Kinases, Sirtuins, Mice, AMP-Activated Protein Kinases, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.